Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer
Status:
Active, not recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety and efficacy of anti PD-1 antibody with
radiation therapy in patients with HER2-negative metastatic breast cancer.